SCHEMBL6090325

SCHEMBL6090325

Cc1ccc(C(=O)Nc2c(C(=O)O)n(Cc3cccc(Cl)c3)c3ccc(-c4ccc(S(C)(=O)=O)cc4)cc23)cc1N

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 10/20 0.42
PLA2G2A P14555 1/20 0.42
SERPINE1 P05121 3/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
ABCB1 P08183 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
MAPK8 P45983 1/20 0.37
P2RY14 Q15391 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092265 0.89 SERPINE1 (0.46) PPARGPLA2G2ASERPINE1ABCB1P2RY14
SCHEMBL5738359 0.84 ADORA3 (0.46) PPARGPLA2G2ASERPINE1PDE4APDE4B
SCHEMBL6091652 0.79 SERPINE1 (0.54) PPARGPLA2G2ASERPINE1P2RY14
SCHEMBL6089976 0.77 PTGES (0.44) PPARGPLA2G2AABCB1MAPT
SCHEMBL5774922 0.76 MAPK8 (0.43) PDE4APDE4BPDE4CPDE4DADORA3
SCHEMBL6091169 0.75 ALDH1A1 (0.46) PPARGPLA2G2ASERPINE1MAPT
SCHEMBL6091490 0.75 TP53 (0.47) PLA2G2AABCB1TP53
SCHEMBL5749488 0.74 PTGER4 (0.46) PPARGPLA2G2ASERPINE1ABCB1MAPT
SCHEMBL6091628 0.73 PLA2G2A (0.41) PPARGPLA2G2AABCB1MAPT
SCHEMBL5777724 0.73 SERPINE1 (0.45) PPARGPLA2G2ASERPINE1MAPTP2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 PPARG 481/4885PLA2G2A 982/4885SERPINE1 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.